Get started
Author

Adrien Chauchet

Observed names: A Chauchet, A. CHAUCHET, A. Chauchet, Adrien Chauchet Sr, CHAUCHET, Adrien, Chauchet Adrien, Chauchet, A, Chauchet, Adrien
Observed institutions: Memorial Sloan Kettering Cancer Center, NewYork–Presbyterian Hospital, University of British Columbia, Inserm, University of Toronto, Université de Lille, Columbia University Irving Medical Center, Centre Hospitalier Universitaire de Lille, Sorbonne Université, Centre Hospitalier Universitaire de Besançon, Centre Hospitalier Universitaire de Montpellier, Laboratoire Chrono-Environnement, Hôpital Lyon Sud, Université Bourgogne Franche-Comté, Établissement Français du Sang, Jiangsu Province Hospital, Institut du Cerveau, Centre Henri Becquerel, Groupe de Recherche sur les formes Injectables et les Technologies Associées, Interactions Hôte-Greffon-Tumeur & Ingénierie Cellulaire et Génique, University of Rochester, Université de Rouen Normandie, Columbia University, Nanjing Medical University, Université de Franche-Comté
ORCID: 0000-0003-3665-6805
Observed ORCID: 0000-0003-3665-6805
OpenAlex ID: A5029209393
Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma
2021 · Hervé Tilly, Franck Morschhauser, et al. · New England Journal of Medicine · 930
A real-world comparison of tisagenlecleucel and axicabtagene ciloleucel CAR T cells in relapsed or refractory diffuse large B cell lymphoma
2022 · Emmanuel Bachy, Steven Le Gouill, et al. · Nature Medicine · 406
PDF
COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)
2021 · Livio Pagano, Jon Salmanton-García, et al. · Journal of Hematology & Oncology · 316
PDF
Radiotherapy or Autologous Stem-Cell Transplantation for Primary CNS Lymphoma in Patients 60 Years of Age and Younger: Results of the Intergroup ANOCEF-GOELAMS Randomized Phase II PRECIS Study
2019 · Caroline Houillier, Luc Taillandier, et al. · Journal of Clinical Oncology · 287
Management and outcome of primary CNS lymphoma in the modern era
2020 · Caroline Houillier, Carole Soussain, et al. · Neurology · 247
Efficacy and tolerability of nivolumab after allogeneic transplantation for relapsed Hodgkin lymphoma
2017 · Charles Herbaux, Jordan Gauthier, et al. · Blood · 217
Prolonged in‐hospital stay and higher mortality after Covid‐19 among patients with non‐Hodgkin lymphoma treated with B‐cell depleting immunotherapy
2021 · Rémy Duléry, Sylvain Lamure, et al. · American Journal of Hematology · 150
PDF
Increased Incidence and Characteristics of Alveolar Echinococcosis in Patients With Immunosuppression-Associated Conditions
2014 · Adrien Chauchet, Frédéric Grenouillet, et al. · Clinical Infectious Diseases · 145
Role of up-front autologous stem-cell transplantation in peripheral T-cell lymphoma for patients in response after induction: an analysis of patients from LYSA centers
2017 · G. Fossard, F. Broussais, et al. · Annals of Oncology · 141
PDF
Commercial anti‐CD19 CAR T cell therapy for patients with relapsed/refractory aggressive B cell lymphoma in a European center
2020 · Pierre Sesques, Emmanuelle Ferrant, et al. · American Journal of Hematology · 138
PDF
Efficacy of chemotherapy or chemo‐anti‐PD‐1 combination after failed anti‐PD‐1 therapy for relapsed and refractory hodgkin lymphoma: A series from lysa centers
2018 · Cédric Rossi, Julia Gilhodes, et al. · American Journal of Hematology · 120
PDF
Radiotherapy or Autologous Stem-Cell Transplantation for Primary CNS Lymphoma in Patients Age 60 Years and Younger: Long-Term Results of the Randomized Phase II PRECIS Study
2022 · Caroline Houillier, Sylvain Dureau, et al. · Journal of Clinical Oncology · 112
Clinical epidemiology of human AE in Europe
2015 · D.A. Vuitton, F. Demonmerot, et al. · Veterinary Parasitology · 96
PDF
Adrenal lymphoma: presentation, management and prognosis
2016 · C. Laurent, O. Casasnovas, et al. · QJM · 75
Determinants of outcome in Covid-19 hospitalized patients with lymphoma: A retrospective multicentric cohort study
2020 · Sylvain Lamure, Rémy Duléry, et al. · EClinicalMedicine · 69
PDF
Efficacy of CAR T-cell therapy is not impaired by previous bispecific antibody treatment in large B-cell lymphoma
2024 · Gilles Crochet, Gloria Iacoboni, et al. · Blood · 66
PDF
Hospital end-of-life care in haematological malignancies
2018 · Yvan Beaussant, Etienne Daguindau, et al. · BMJ Supportive & Palliative Care · 64
PDF
Intravenous high‐dose methotrexate based systemic therapy in the treatment of isolated primary vitreoretinal lymphoma: An LOC network study
2021 · Marion Lam, Valérie Touitou, et al. · American Journal of Hematology · 60
PDF
First‐line treatment of double‐hit and triple‐hit lymphomas: Survival and tolerance data from a retrospective multicenter French study
2020 · Marie‐Charlotte Laude, Laure Lebras, et al. · American Journal of Hematology · 54
PDF
Outcomes after first-line immunochemotherapy for primary mediastinal B-cell lymphoma: a LYSA study
2021 · Vincent Camus, Cédric Rossi, et al. · Blood Advances · 52
PDF
Early 18F-FDG PET/CT Response Predicts Survival in Relapsed or Refractory Hodgkin Lymphoma Treated with Nivolumab
2019 · Aiping Chen, Fatima-Zohra Mokrane, et al. · Journal of Nuclear Medicine · 46
PDF
Long-term efficacy of anti-PD1 therapy in Hodgkin lymphoma with and without allogenic stem cell transplantation
2019 · Guillaume Manson, Jean-Baptiste Mear, et al. · European Journal of Cancer · 46
PDF
Five-Year Outcomes of the POLARIX Study Comparing Pola-R-CHP and R-CHOP in Patients With Diffuse Large B-Cell Lymphoma
2025 · Franck Morschhauser, Gilles Salles, et al. · Journal of Clinical Oncology · 45
PDF
French Intensive Care Society, International congress – Réanimation 2016
2016 · Jaillette, E, Girault, C, et al. · Annals of Intensive Care · 42
PDF
Novel prognostic scoring systems for severe CRS and ICANS after anti-CD19 CAR T cells in large B-cell lymphoma
2024 · Pierre Sesques, Amy A. Kirkwood, et al. · Journal of Hematology & Oncology · 38
PDF
Works count: 155
Citation count: 4,575
H-index: 29
I10-index: 45
Year
Topic
Type